Literature DB >> 17653250

A survey of colonoscopy capacity in New Zealand's public hospitals.

Andrew Yeoman1, Susan Parry.   

Abstract

AIMS: Population screening for colorectal cancer (CRC) in New Zealand is under review and would increase demand for colonoscopy. This National Screening Unit commissioned survey aimed to determine the current level of colonoscopy provision in New Zealand's public hospitals, the gap in demand and provision for diagnostic and surveillance procedures, and factors limiting colonoscopy capacity.
METHOD: A survey, based on the United States SECAP study, was posted to all public endoscopy units within New Zealand in April 2005.
RESULTS: The overall survey response rate was 86% (24/28). Only 3 of 7 large centres, and 11 of 17 small centres, are able to offer a diagnostic colonoscopy to patients with symptoms suggestive of CRC within 3 months of referral--and at the time of the survey, 828 patients had been waiting greater than 6 months. The majority (85%) of public hospitals offer surveillance colonoscopy for most indications, and at the time of the survey, 2550 patients had been waiting greater than 6 months. Availability of endoscopy nurses and endoscopists are the main factors limiting colonoscopy provision.
CONCLUSION: In New Zealand's public hospitals a significant gap exists between colonoscopy demand and provision. Population screening for CRC would require a significant increase in colonoscopy capacity to ensure waiting times for symptomatic patients do not increase.

Entities:  

Mesh:

Year:  2007        PMID: 17653250

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  2 in total

Review 1.  Cost-effectiveness of colorectal cancer screening.

Authors:  Iris Lansdorp-Vogelaar; Amy B Knudsen; Hermann Brenner
Journal:  Epidemiol Rev       Date:  2011-06-01       Impact factor: 6.222

2.  Adherence to surveillance guidelines after removal of colorectal adenomas: a large, community-based study.

Authors:  Else-Mariëtte B van Heijningen; Iris Lansdorp-Vogelaar; Ewout W Steyerberg; S Lucas Goede; Evelien Dekker; Wilco Lesterhuis; Frank ter Borg; Juda Vecht; Pieter Spoelstra; Leopold Engels; Clemens J M Bolwerk; Robin Timmer; Jan H Kleibeuker; Jan J Koornstra; Harry J de Koning; Ernst J Kuipers; Marjolein van Ballegooijen
Journal:  Gut       Date:  2015-01-13       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.